Human placental extract suppresses mast cell activation and induces mast cell apoptosis.

Allergy Degranulation Human placental extract Mast cell Mast cell activation Passive cutaneous anaphylaxis

Journal

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 01 08 2022
accepted: 18 10 2023
medline: 28 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Human placental extract (HPE) has been documented to facilitate the healing of certain disorders including allergy. However, the effects of HPE on the functionality of mast cells, a critical cell type in allergic diseases, have not been reported. To investigate the effects of HPE on the regulation of allergy with respect to the biological functions of mast cells, the mast cell line C57 or HMC-1 cells were treated with HPE followed by the assessment of cell proliferation, apoptosis, activation, chemotaxis and phagocytosis. Mouse peritoneal mast cells were also investigated for their responses to induction of apoptosis by HPE in vivo. Furthermore, the effect of HPE on mast cell degranulation was confirmed using the passive cutaneous anaphylaxis (PCA) assay, an acute allergy model. HPE was capable of suppressing mast cell proliferation and inducing mast cell apoptosis. Mast cell degranulation in response to compound 48/80- or anti-DNP IgE and DNP-mediated activation was suppressed. In addition, treatment with HPE compromised the production of cytokines by mast cells and cell chemotaxis. These observations were consistent with the dampened passive cutaneous anaphylaxis (PCA) assay following treatment with HPE. This study revealed a suppressive effect of HPE on overall mast cell activities, suggesting a potential regulatory role of HPE on the alleviation of allergic diseases through mast cells.

Sections du résumé

BACKGROUND BACKGROUND
Human placental extract (HPE) has been documented to facilitate the healing of certain disorders including allergy. However, the effects of HPE on the functionality of mast cells, a critical cell type in allergic diseases, have not been reported.
METHODS METHODS
To investigate the effects of HPE on the regulation of allergy with respect to the biological functions of mast cells, the mast cell line C57 or HMC-1 cells were treated with HPE followed by the assessment of cell proliferation, apoptosis, activation, chemotaxis and phagocytosis. Mouse peritoneal mast cells were also investigated for their responses to induction of apoptosis by HPE in vivo. Furthermore, the effect of HPE on mast cell degranulation was confirmed using the passive cutaneous anaphylaxis (PCA) assay, an acute allergy model.
RESULTS RESULTS
HPE was capable of suppressing mast cell proliferation and inducing mast cell apoptosis. Mast cell degranulation in response to compound 48/80- or anti-DNP IgE and DNP-mediated activation was suppressed. In addition, treatment with HPE compromised the production of cytokines by mast cells and cell chemotaxis. These observations were consistent with the dampened passive cutaneous anaphylaxis (PCA) assay following treatment with HPE.
CONCLUSION CONCLUSIONS
This study revealed a suppressive effect of HPE on overall mast cell activities, suggesting a potential regulatory role of HPE on the alleviation of allergic diseases through mast cells.

Identifiants

pubmed: 38012745
doi: 10.1186/s13223-023-00850-y
pii: 10.1186/s13223-023-00850-y
pmc: PMC10683163
doi:

Types de publication

Journal Article

Langues

eng

Pagination

98

Subventions

Organisme : National Natural Science Foundation of China
ID : 81760294
Organisme : National Natural Science Foundation of China
ID : 82260324
Organisme : National Natural Science Foundation of China
ID : 82201968
Organisme : Guizhou Provincial Innovative Talents Team Program
ID : 2019-5610
Organisme : Health Commission of Guizhou Province
ID : gzwkj2022-064
Organisme : Health Commission of Guizhou Province
ID : gzwkj2022-267
Organisme : Health Commission of Guizhou Province
ID : gzwkj2021-361

Informations de copyright

© 2023. The Author(s).

Références

Int Immunopharmacol. 2011 Aug;11(8):1002-11
pubmed: 21356342
Nat Immunol. 2007 Oct;8(10):1095-104
pubmed: 17767162
Front Immunol. 2021 Sep 27;12:736692
pubmed: 34646271
J Leukoc Biol. 1997 Mar;61(3):233-45
pubmed: 9060446
Health Sci Rep. 2022 Feb 18;5(2):e522
pubmed: 35224222
Front Immunol. 2021 Jul 22;12:692733
pubmed: 34367151
J Reprod Immunol. 1986 Jul;9(2):85-94
pubmed: 3746778
Am J Respir Crit Care Med. 2016 Feb 15;193(4):376-85
pubmed: 26474238
Cancer Res. 2000 Dec 1;60(23):6757-62
pubmed: 11118063
Front Immunol. 2012 Feb 20;3:16
pubmed: 22566901
Zhonghua Yi Xue Za Zhi. 2017 Jun 20;97(23):1815-1819
pubmed: 28648005
J Wound Care. 2009 Nov;18(11):462, 464-7
pubmed: 19901875
J Indian Med Assoc. 1990 Nov;88(11):314-6
pubmed: 2086662
Eur J Pain. 2000;4(4):403-8
pubmed: 11124012
J Integr Med. 2017 Mar;15(2):135-141
pubmed: 28285618
Front Pediatr. 2019 Jun 18;7:246
pubmed: 31275909
Laryngoscope. 2014 Oct;124(10):E399-404
pubmed: 24729028
J Neurosci Res. 2004 Nov 1;78(3):362-70
pubmed: 15389837
BMC Complement Altern Med. 2018 Dec 12;18(1):331
pubmed: 30541534
Nature. 1986 Nov 6-12;324(6092):65-7
pubmed: 3491321
Taiwan J Obstet Gynecol. 2020 Sep;59(5):675-681
pubmed: 32917317
Curr Opin Immunol. 2018 Feb;50:39-47
pubmed: 29144996
J Physiol. 2001 Aug 15;535(Pt 1):207-15
pubmed: 11507170
J Immunol. 1993 Oct 1;151(7):3853-65
pubmed: 8376806
J Allergy Clin Immunol. 2019 Aug;144(2):353-360
pubmed: 31395149
J Exp Med. 1991 Jul 1;174(1):125-31
pubmed: 1711559
Nature. 2008 Jul 24;454(7203):445-54
pubmed: 18650915
Am J Respir Cell Mol Biol. 1994 May;10(5):471-80
pubmed: 8179909
Biol Pharm Bull. 2003 Oct;26(10):1472-7
pubmed: 14519957
J Immunol. 1994 Oct 15;153(8):3717-23
pubmed: 7523504
Mol Cancer Ther. 2010 Jan;9(1):211-23
pubmed: 20053766
Blood Adv. 2018 Sep 11;2(17):2273-2281
pubmed: 30206100
Int J Mol Sci. 2021 May 07;22(9):
pubmed: 34067047
Nat Med. 2012 May 04;18(5):693-704
pubmed: 22561833
Nat Prod Res. 2011 Jul;25(11):1090-100
pubmed: 21726131
Front Nutr. 2020 Oct 20;7:550287
pubmed: 33195361
J Allergy Clin Immunol. 2013 Oct;132(4):959-68
pubmed: 23683463
Nat Rev Immunol. 2016 Nov;16(11):676-689
pubmed: 27640624
Microb Pathog. 2017 Oct;111:307-315
pubmed: 28867635
Nat Immunol. 2017 Sep 19;18(10):1076-1083
pubmed: 28926539
Immunol Rev. 2018 Mar;282(1):121-150
pubmed: 29431212
J Immunol. 2010 Sep 1;185(5):2935-41
pubmed: 20675596
Allergy. 2012 Oct;67(10):1233-40
pubmed: 22845035
Annu Rev Immunol. 1989;7:59-76
pubmed: 2653378
Biomed Res Int. 2019 Apr 17;2019:1315257
pubmed: 31111043
J Immunol. 2014 May 15;192(10):4859-66
pubmed: 24733849
Ann Plast Surg. 2010 Jul;65(1):96-100
pubmed: 20548228
Immunology. 2015 Mar;144(3):387-394
pubmed: 25196548

Auteurs

Tongqian Wu (T)

Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyi Street 28, Guiyang, 550004, Guizhou, China.
School of Laboratory Science, Guizhou Medical University, Guiyang, China.
Clinical Research Center, Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Jingjing He (J)

School of Laboratory Science, Guizhou Medical University, Guiyang, China.

Shirong Yan (S)

Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyi Street 28, Guiyang, 550004, Guizhou, China.
School of Laboratory Science, Guizhou Medical University, Guiyang, China.

Jing Li (J)

Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyi Street 28, Guiyang, 550004, Guizhou, China.
School of Laboratory Science, Guizhou Medical University, Guiyang, China.

Ke Chen (K)

School of Laboratory Science, Guizhou Medical University, Guiyang, China.

Dingshan Zhang (D)

School of Laboratory Science, Guizhou Medical University, Guiyang, China.

Mingliang Cheng (M)

Department of Infectious Disease, Affiliated Hospital of Guizhou Medical University, Guiyi Street 28, Guiyang, 550004, Guizhou, China. minglianggy@126.com.

Zou Xiang (Z)

Department of Health Technology and Informatics, Faculty of Health and Social Science, The Hong Kong Polytechnic University, Hong Kong, China. xiang.y.zou@polyu.edu.hk.

Yu Fang (Y)

Center for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyi Street 28, Guiyang, 550004, Guizhou, China. yu.fang@gmc.edu.cn.
School of Laboratory Science, Guizhou Medical University, Guiyang, China. yu.fang@gmc.edu.cn.

Classifications MeSH